Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gruben

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
RMD Open|October 19, 2016
Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trialVibeke Strand, Eun Bong Lee, Roy Fleischmann, et al.
International Journal of Rheumatic Diseases|July 26, 2016
Efficacy and safety of tofacitinib in patients with active rheumatoid arthritis: review of key Phase 2 studiesRoy Fleischmann, Joel Kremer, Yoshiya Tanaka, et al.
Inflammatory Bowel Diseases|September 26, 2024
Health-Related Quality of Life Outcomes With Etrasimod Treatment in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From ELEVATE UC 52 and ELEVATE UC 12Alessandro Armuzzi, David T Rubin, Stefan Schreiber, et al.
Arthritis Research & Therapy|June 24, 2016
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritisMark C Genovese, Ronald F van Vollenhoven, Bethanie Wilkinson, et al.
Rheumatology and Therapy|November 1, 2024
Tofacitinib Safety and Effectiveness in Canadian Patients with Rheumatoid Arthritis by Cardiovascular Risk Enrichment: Subanalysis of the CANTORAL StudyBoulos Haraoui, Majed Khraishi, Denis Choquette, et al.
BMC Health Services Research|June 3, 2026
Characteristics, all-cause healthcare resource utilisation, and costs among high-risk adults with long COVID during Omicron predominance, 2022-2023: a retrospective cohort study using UK primary care dataJingyan Yang, Kiran K Rai, Hannah Gowman, et al.
RMD Open|May 13, 2020
Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitisAlexis Ogdie, Kurt de Vlam, Iain B McInnes, et al.
The New England Journal of Medicine|August 10, 2012
Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritisRoy Fleischmann, Joel Kremer, John Cush, et al.
International Journal of Rheumatic Diseases|April 21, 2026
Real-World Data of Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Taiwanese Patients With Rheumatoid Arthritis From a Drug-Based Cohort StudySong-Chou Hsieh, Wei-Sheng Chen, Jui-Chieh Hu, et al.
RMD Open|March 23, 2023
Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extensionLihi Eder, Dafna D Gladman, Philip Mease, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
RMD Open|October 19, 2016
Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trialVibeke Strand, Eun Bong Lee, Roy Fleischmann, et al.
International Journal of Rheumatic Diseases|July 26, 2016
Efficacy and safety of tofacitinib in patients with active rheumatoid arthritis: review of key Phase 2 studiesRoy Fleischmann, Joel Kremer, Yoshiya Tanaka, et al.
Inflammatory Bowel Diseases|September 26, 2024
Health-Related Quality of Life Outcomes With Etrasimod Treatment in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From ELEVATE UC 52 and ELEVATE UC 12Alessandro Armuzzi, David T Rubin, Stefan Schreiber, et al.
Arthritis Research & Therapy|June 24, 2016
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritisMark C Genovese, Ronald F van Vollenhoven, Bethanie Wilkinson, et al.
Rheumatology and Therapy|November 1, 2024
Tofacitinib Safety and Effectiveness in Canadian Patients with Rheumatoid Arthritis by Cardiovascular Risk Enrichment: Subanalysis of the CANTORAL StudyBoulos Haraoui, Majed Khraishi, Denis Choquette, et al.
BMC Health Services Research|June 3, 2026
Characteristics, all-cause healthcare resource utilisation, and costs among high-risk adults with long COVID during Omicron predominance, 2022-2023: a retrospective cohort study using UK primary care dataJingyan Yang, Kiran K Rai, Hannah Gowman, et al.
RMD Open|May 13, 2020
Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitisAlexis Ogdie, Kurt de Vlam, Iain B McInnes, et al.
The New England Journal of Medicine|August 10, 2012
Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritisRoy Fleischmann, Joel Kremer, John Cush, et al.
International Journal of Rheumatic Diseases|April 21, 2026
Real-World Data of Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Taiwanese Patients With Rheumatoid Arthritis From a Drug-Based Cohort StudySong-Chou Hsieh, Wei-Sheng Chen, Jui-Chieh Hu, et al.
RMD Open|March 23, 2023
Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extensionLihi Eder, Dafna D Gladman, Philip Mease, et al.
Pageof 7